<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kang DJ</submitter><funding>BLRD VA</funding><funding>VA Merit Review</funding><funding>NIDDK NIH HHS</funding><funding>NIAAA NIH HHS</funding><funding>NIDDK</funding><funding>McGuire Research Institute</funding><funding>National Gnotobiotic Rodent Resource Center (NGRRC)</funding><funding>NIH HHS</funding><funding>CSRD VA</funding><pagination>1232-48</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5033692</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>64(4)</volume><pubmed_abstract>&lt;h4>Unlabelled&lt;/h4>The mechanisms behind the development of hepatic encephalopathy (HE) are unclear, although hyperammonemia and systemic inflammation through gut dysbiosis have been proposed. The aim of this work was to define the individual contribution of hyperammonemia and systemic inflammation on neuroinflammation in cirrhosis using germ-free (GF) and conventional mice. GF and conventional C57BL/6 mice were made cirrhotic using CCl4 gavage. These were compared to their noncirrhotic counterparts. Intestinal microbiota, systemic and neuroinflammation (including microglial and glial activation), serum ammonia, intestinal glutaminase activity, and cecal glutamine content were compared between groups. GF cirrhotic mice developed similar cirrhotic changes to conventional mice after 4 extra </pubmed_abstract><journal>Hepatology (Baltimore, Md.)</journal><pubmed_title>Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice.</pubmed_title><pmcid>PMC5033692</pmcid><funding_grant_id>R01 AA020203</funding_grant_id><funding_grant_id>5-P30-DK034987</funding_grant_id><funding_grant_id>I01 CX001076</funding_grant_id><funding_grant_id>P30 DK034987</funding_grant_id><funding_grant_id>I01 BX001328</funding_grant_id><funding_grant_id>5-P40-OD010995</funding_grant_id><funding_grant_id>R01DK089713</funding_grant_id><funding_grant_id>P40 OD010995</funding_grant_id><funding_grant_id>CX10076</funding_grant_id><funding_grant_id>R01 DK087913</funding_grant_id><pubmed_authors>Kang DJ</pubmed_authors><pubmed_authors>Ghosh SA</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Bajaj JS</pubmed_authors><pubmed_authors>Liu R</pubmed_authors><pubmed_authors>Betrapally NS</pubmed_authors><pubmed_authors>Jiao C</pubmed_authors><pubmed_authors>Lippman HR</pubmed_authors><pubmed_authors>Hylemon PB</pubmed_authors><pubmed_authors>Sikaroodi M</pubmed_authors><pubmed_authors>Sartor RB</pubmed_authors><pubmed_authors>Sanyal AJ</pubmed_authors><pubmed_authors>Brown RR</pubmed_authors><pubmed_authors>Herzog J</pubmed_authors><pubmed_authors>Gillevet PM</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Carl D</pubmed_authors><pubmed_authors>Zhou H</pubmed_authors><pubmed_authors>Heuman DM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice.</name><description>&lt;h4>Unlabelled&lt;/h4>The mechanisms behind the development of hepatic encephalopathy (HE) are unclear, although hyperammonemia and systemic inflammation through gut dysbiosis have been proposed. The aim of this work was to define the individual contribution of hyperammonemia and systemic inflammation on neuroinflammation in cirrhosis using germ-free (GF) and conventional mice. GF and conventional C57BL/6 mice were made cirrhotic using CCl4 gavage. These were compared to their noncirrhotic counterparts. Intestinal microbiota, systemic and neuroinflammation (including microglial and glial activation), serum ammonia, intestinal glutaminase activity, and cecal glutamine content were compared between groups. GF cirrhotic mice developed similar cirrhotic changes to conventional mice after 4 extra </description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Oct</publication><modification>2025-04-19T03:03:10.552Z</modification><creation>2019-03-27T02:24:54Z</creation></dates><accession>S-EPMC5033692</accession><cross_references><pubmed>27339732</pubmed><doi>10.1002/hep.28696</doi></cross_references></HashMap>